BACHEM HOLDING AG banner

Company Overview

Business Description

Sector
Health Care
Industry
Life Sciences Tools & Services
Headquarters
Switzerland CH
Employees
2 511
IPO date
Jun 29, 2001

Bachem Holding AG makes custom peptide and oligonucleotide ingredients for the pharmaceutical industry. In plain English, it helps drug makers design and produce hard-to-make molecules that often become the active part of medicines, especially in areas like diabetes, cancer, and rare diseases. Its customers are mainly big drug companies and biotech firms that need a specialist partner to develop and manufacture these compounds under strict quality rules.

Bachem does not sell finished pills to consumers. It earns money by acting as a contract developer and manufacturer, charging customers for research support, process development, and commercial production of active pharmaceutical ingredients. That means its business is tied to how many programs pharma companies move forward and how much custom manufacturing they outsource.

What makes Bachem different is its focus on complex, small-batch chemical and biotech manufacturing. Peptides and oligonucleotides are important but technically demanding ingredients, so customers rely on firms like Bachem for expertise, regulatory know-how, and reliable production capacity. In the drug supply chain, Bachem sits upstream as a specialist supplier that turns complex molecule designs into manufacturing reality.

BACHEM HOLDING AG Investor Relations

Address
Hauptstrasse 144
Bubendorf, Basel-Landschaft
Switzerland

Business Segments

Peptide ingredients

Bachem develops and manufactures custom peptides and peptide-based active ingredients that are used in medicines and research. This includes work from early development through commercial supply.

Customers and revenue model

Oligonucleotide ingredients

Bachem makes custom oligonucleotides, which are short strands of synthetic nucleic acids used in drug discovery, diagnostics, and some therapies.

Customers and revenue model

Management

Mr. Michael Suter

Vice President of Global Accounting

Biography unavailable

Dr. Gunther Loidl

Chief Technology Officer

Biography unavailable

Mr. Achim Pluckebaum

Chief Information Officer

Biography unavailable

Dr. Daniel Grotzky

Head of Group Communications

Biography unavailable

Viviane Minden

Chief Human Resources Officer

Biography unavailable

Dr. Anne-Kathrin Stoller Ph.D.

Chief Operating Officer of Bachem Americas, Inc.

Biography unavailable

Dr. Torsten Wohr

Chief Commercial Officer

Biography unavailable

Mr. Boris Corpataux

VP & Head Global Strategic Alliances

Biography unavailable

Mr. Chris McGee

VP & Head Global Business Development

Biography unavailable

Mr. Daniel Samson

VP & Head Oligonucleotides

Biography unavailable

1 / 10